Breast cancer data analyzed by race/ethnic groups to identify differences in diagnosis, prognosis
the ONA take:
According to a new study published in the journal JAMA, researchers from Women's College Hospital in Toronto, Ontario, Canada, have found that race and ethnicity may play a role in the timing of breast cancer diagnosis and the prognosis of the woman's disease.
For the study, researchers sought to investigate whether biological differences in tumor aggressiveness affect differences in early-stage breast cancer diagnosis by ethnicity and race.
They identified 373,563 women diagnosed with stage 1 breast cancer from the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2011. Women were followed for an average of 40.6 months. Researchers then categorized those women based on race and ethnicity and assessed the biological aggressiveness of the tumors.
They also assessed timing of diagnosis and prognosis based on race/ethnic group. Results showed that Japanese women were more likely to be diagnosed with stage 1 breast cancer than non-Hispanic white women.
In addition, black and South Asian women were more likely to be diagnosed at a later stage than non-Hispanic white women, and black women were more likely to die from stage 1 disease than non-Hispanic white women and South Asian women. Black women were also more likely to die from small-sized tumors than non-Hispanic white women.
When analyzing biological differences in tumor aggressiveness, they found that black women with small-sized tumors were more likely to have triple-negative disease and to present with local and distant metastases than non-Hispanic white women. The researchers note that socioeconomic factors and access to health care may also play a role.
Race and ethnicity may play a role in the timing of breast cancer diagnosis and the prognosis of the woman's disease.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|